Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30

$3.87+0.15 (+4.03%)

Close on Nov 13, 2026Market cap $143.89MP/E –Yield –

Armata Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2014 it was 5650.1%, against -79732.1% the year before.

Period	Period end	Value	Change (pts)
FY2014	Dec 31, 2014	5650.1%	+85382.2
FY2013	Dec 31, 2013	-79732.1%	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q2 FY2020	Jun 30, 2020	-15193.5%	–

See a number that looks wrong?